Trulieve Cannabis Corp. SEC filings TRLV

Trulieve Cannabis Corp. has 416 filings in SEC EDGAR's recent list, going back to Oct 2, 2018. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Trulieve Cannabis Corp. SEC filings
Form Description Filed Period
S-8 POS Filing Aug 24, 2026 —
S-8 Employee stock plan registration Aug 6, 2025 —
S-3ASR Automatic shelf registration Jun 30, 2025 —
S-8 Employee stock plan registration Jun 21, 2024 —
S-8 Employee stock plan registration Jun 28, 2023 —
FWP Free writing prospectus Jul 8, 2022 —
S-3ASR Automatic shelf registration Jul 8, 2022 —
POS AM Filing Jul 7, 2022 —
POS AM Filing Jul 7, 2022 —
424B3 Prospectus Jan 31, 2022 —
S-1 Registration statement Jan 21, 2022 —
POS AM Filing Jan 21, 2022 —
S-8 Employee stock plan registration Oct 6, 2021 —
POS AM Filing Sep 15, 2021 —
S-8 Employee stock plan registration Aug 30, 2021 —
424B4 Prospectus Apr 8, 2021 —
POS AM Post-effective amendment no. 1 to form s-1 Apr 8, 2021 —
S-1 Registration statement Apr 5, 2021 —
POS AM Filing Mar 23, 2021 —
424B3 Prospectus Feb 8, 2021 —
S-1/A Amended registration statement Feb 2, 2021 —
S-1 Registration statement Jan 12, 2021 —

Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
TRLV (NYSE)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Tallahassee, FL
SEC filer status
Large accelerated filer
SEC CIK
1754195

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.